Summary: Pro-apoptotic Bcl-2 protein, BAD
Pfam includes annotations and additional family information from a range of different sources. These sources can be accessed via the tabs below.
This is the Wikipedia entry entitled "Bcl-2-associated death promoter". More...
Bcl-2-associated death promoter Edit Wikipedia article
| Pro-apoptotic Bcl-2 protein, BAD | |||||||||
|---|---|---|---|---|---|---|---|---|---|
complex of bcl-xl with peptide from bad |
|||||||||
| Identifiers | |||||||||
| Symbol | Bcl-2_BAD | ||||||||
| Pfam | PF10514 | ||||||||
| InterPro | IPR018868 | ||||||||
|
|||||||||
The Bcl-2-associated death promoter (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family which is involved in initiating apoptosis. BAD is a member of the BH3-only family ,[1] a subfamily of the Bcl-2 family. It does not contain a C-terminal transmembrane domain for outer mitochondrial membrane and nuclear envelope targeting, unlike most other members of the Bcl-2 family.[2] After activation, it is able to form a heterodimer with anti-apoptotic proteins and prevent them from stopping apoptosis.
Contents |
[edit] Mechanism of Action
Bax/Bak are believed to initiate apoptosis by forming a pore in the mitochondrial outer membrane that allows cytochrome c to escape into the cytoplasm and activate the pro-apoptotic caspase cascade. The anti-apoptotic Bcl-2 and Bcl-xL proteins inhibit cytochrome c release through the mitochondrial pore and also inhibit activation of the cytoplasmic caspase cascade by cytochrome c.[3]
Dephosphorylated BAD forms a heterodimer with Bcl-2 and Bcl-xL, inactivating them and thus allowing Bax/Bak-triggered apoptosis. When BAD is phosphorylated by Akt/protein kinase B (triggered by PIP3), it forms the BAD-(14-3-3)protein homodimer. This leaves Bcl-2 free to inhibit Bax-triggered apoptosis.[4] BAD phosphorylation is thus anti-apoptotic, and BAD dephosphorylation (e.g., by Ca2+-stimulated Calcineurin) is pro-apoptotic. The latter may be involved in neural diseases such as schizophrenia.[5]
[edit] Interactions
Bcl-2-associated death promoter has been shown to interact with BCL2-like 1,[6][7][8][9][10][11][12][13][14][15][16] BCL2L2,[6][10][17][18] Bcl-2,[6][12] BCL2-related protein A1,[6][17] YWHAQ,[6][19] YWHAZ,[20] MCL1[6][17] and S100A10.[19]
[edit] See also
[edit] References
- ^ Adachi M. and Imai K. (2002). "The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2". Cell death and differentiation 9 (11): 1240â1247. doi:10.1038/sj.cdd.4401097. PMID 12404123.
- ^ Sheau Yu Hsu et al. (1997). "Interference of BAD (Bcl-xL/Bcl-2-Associated Death Promoter)-Induced Apoptosis in Mammalian Cells by 14â3-3 Isoforms and P11". Molecular Endocrinology 11 (12): 1858â1867. doi:10.1210/me.11.12.1858. PMID 9369453.
- ^ Helmreich, E.J.M. (2001) The Biochemistry of Cell Signalling, pp. 238-43
- ^ E.J.M. (2001) The Biochemistry of Cell Signalling, pp. 242
- ^ Foster, T.C. et al. (2001) J. Neurosci. 21, 4066-4073, "Calcineurin Links Ca++ Dysregulation with Brain Aging"(
- ^ a b c d e f Chen, Lin; Willis Simon N, Wei Andrew, Smith Brian J, Fletcher Jamie I, Hinds Mark G, Colman Peter M, Day Catherine L, Adams Jerry M, Huang David C S (February 2005). "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function". Mol. Cell (United States) 17 (3): 393â403. doi:10.1016/j.molcel.2004.12.030. ISSN 1097-2765. PMID 15694340.
- ^ Jin, Zhaohui; Xin Meiguo, Deng Xingming (April 2005). "Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase". J. Biol. Chem. (United States) 280 (16): 16045â52. doi:10.1074/jbc.M413488200. ISSN 0021-9258. PMID 15705582.
- ^ Strobel, T; Tai Y T, Korsmeyer S, Cannistra S A (November 1998). "BAD partly reverses paclitaxel resistance in human ovarian cancer cells". Oncogene (ENGLAND) 17 (19): 2419â27. doi:10.1038/sj.onc.1202180. ISSN 0950-9232. PMID 9824152.
- ^ Zhang, Haichao; Nimmer Paul, Rosenberg Saul H, Ng Shi-Chung, Joseph Mary (August 2002). "Development of a high-throughput fluorescence polarization assay for Bcl-x(L)". Anal. Biochem. (United States) 307 (1): 70â5. doi:10.1016/S0003-2697(02)00028-3. ISSN 0003-2697. PMID 12137781.
- ^ a b Ayllón, Verónica; Cayla Xavier, GarcÃa Alphonse, Fleischer Aarne, Rebollo Angelita (July 2002). "The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad". Eur. J. Immunol. (Germany) 32 (7): 1847â55. doi:10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7. ISSN 0014-2980. PMID 12115603.
- ^ Komatsu, K; Miyashita T, Hang H, Hopkins K M, Zheng W, Cuddeback S, Yamada M, Lieberman H B, Wang H G (January 2000). "Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis". Nat. Cell Biol. (ENGLAND) 2 (1): 1â6. doi:10.1038/71316. ISSN 1465-7392. PMID 10620799.
- ^ a b Yang, E; Zha J, Jockel J, Boise L H, Thompson C B, Korsmeyer S J (January 1995). "Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death". Cell (UNITED STATES) 80 (2): 285â91. doi:10.1016/0092-8674(95)90411-5. ISSN 0092-8674. PMID 7834748.
- ^ Petros, A M; Nettesheim D G, Wang Y, Olejniczak E T, Meadows R P, Mack J, Swift K, Matayoshi E D, Zhang H, Thompson C B, Fesik S W (Dec. 2000). "Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies". Protein Sci. (United States) 9 (12): 2528â34. doi:10.1110/ps.9.12.2528. ISSN 0961-8368. PMC 2144516. PMID 11206074.
- ^ Chattopadhyay, A; Chiang C W, Yang E (July 2001). "BAD/BCL-[X(L)] heterodimerization leads to bypass of G0/G1 arrest". Oncogene (England) 20 (33): 4507â18. doi:10.1038/sj.onc.1204584. ISSN 0950-9232. PMID 11494146.
- ^ Iwahashi, H; Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y (November 1997). "Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy". Nature (ENGLAND) 390 (6658): 413â7. doi:10.1038/37144. ISSN 0028-0836. PMID 9389483.
- ^ Komatsu, K; Wharton W, Hang H, Wu C, Singh S, Lieberman H B, Pledger W J, Wang H G (November 2000). "PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition". Oncogene (ENGLAND) 19 (46): 5291â7. doi:10.1038/sj.onc.1203901. ISSN 0950-9232. PMID 11077446.
- ^ a b c Bae, J; Hsu S Y, Leo C P, Zell K, Hsueh A J (October 2001). "Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis". Apoptosis (United States) 6 (5): 319â30. doi:10.1023/A:1011319901057. ISSN 1360-8185. PMID 11483855.
- ^ Holmgreen, S P; Huang D C, Adams J M, Cory S (June 1999). "Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members". Cell Death Differ. (ENGLAND) 6 (6): 525â32. doi:10.1038/sj.cdd.4400519. ISSN 1350-9047. PMID 10381646.
- ^ a b Hsu, S Y; Kaipia A, Zhu L, Hsueh A J (November 1997). "Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11". Mol. Endocrinol. (UNITED STATES) 11 (12): 1858â67. doi:10.1210/me.11.12.1858. ISSN 0888-8809. PMID 9369453.
- ^ Yang, H; Masters S C, Wang H, Fu H (June 2001). "The proapoptotic protein Bad binds the amphipathic groove of 14-3-3zeta". Biochim. Biophys. Acta (Netherlands) 1547 (2): 313â9. doi:10.1016/S0167-4838(01)00202-3. ISSN 0006-3002. PMID 11410287.
[edit] Further reading
- Tolstrup M, Ostergaard L, Laursen AL et al. (2004). "HIV/SIV escape from immune surveillance: focus on Nef". Curr. HIV Res. 2 (2): 141â51. doi:10.2174/1570162043484924. PMID 15078178.
- Jiang P, Du W, Wu M (2007). "p53 and Bad: remote strangers become close friends". Cell Res. 17 (4): 283â5. doi:10.1038/cr.2007.19. PMID 17404594.
- Yang E, Zha J, Jockel J et al. (1995). "Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death". Cell 80 (2): 285â91. doi:10.1016/0092-8674(95)90411-5. PMID 7834748.
- Zha J, Harada H, Yang E et al. (1997). "Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)". Cell 87 (4): 619â28. doi:10.1016/S0092-8674(00)81382-3. PMID 8929531.
- Wang HG, Rapp UR, Reed JC (1997). "Bcl-2 targets the protein kinase Raf-1 to mitochondria". Cell 87 (4): 629â38. doi:10.1016/S0092-8674(00)81383-5. PMID 8929532.
- Inohara N, Ding L, Chen S, Núñez G (1997). "harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L)". EMBO J. 16 (7): 1686â94. doi:10.1093/emboj/16.7.1686. PMC 1169772. PMID 9130713.
- Zha J, Harada H, Osipov K et al. (1997). "BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity". J. Biol. Chem. 272 (39): 24101â4. doi:10.1074/jbc.272.39.24101. PMID 9305851.
- Hsu SY, Kaipia A, Zhu L, Hsueh AJ (1997). "Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11". Mol. Endocrinol. 11 (12): 1858â67. doi:10.1210/me.11.12.1858. PMID 9369453.
- del Peso L, González-GarcÃa M, Page C et al. (1997). "Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt". Science 278 (5338): 687â9. doi:10.1126/science.278.5338.687. PMID 9381178.
- Ottilie S, Diaz JL, Horne W et al. (1998). "Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins". J. Biol. Chem. 272 (49): 30866â72. doi:10.1074/jbc.272.49.30866. PMID 9388232.
- Huang DC, Adams JM, Cory S (1998). "The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4". EMBO J. 17 (4): 1029â39. doi:10.1093/emboj/17.4.1029. PMC 1170452. PMID 9463381.
- Blume-Jensen P, Janknecht R, Hunter T (1998). "The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136". Curr. Biol. 8 (13): 779â82. doi:10.1016/S0960-9822(98)70302-1. PMID 9651683.
- Strobel T, Tai YT, Korsmeyer S, Cannistra SA (1998). "BAD partly reverses paclitaxel resistance in human ovarian cancer cells". Oncogene 17 (19): 2419â27. doi:10.1038/sj.onc.1202180. PMID 9824152.
- Song Q, Kuang Y, Dixit VM, Vincenz C (1999). "Boo, a novel negative regulator of cell death, interacts with Apaf-1". EMBO J. 18 (1): 167â78. doi:10.1093/emboj/18.1.167. PMC 1171112. PMID 9878060.
- Yasuda M, Han JW, Dionne CA et al. (1999). "BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3". Cancer Res. 59 (3): 533â7. PMID 9973195.
- Wang HG, Pathan N, Ethell IM et al. (1999). "Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD". Science 284 (5412): 339â43. doi:10.1126/science.284.5412.339. PMID 10195903.
- Holmgreen SP, Huang DC, Adams JM, Cory S (1999). "Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members". Cell Death Differ. 6 (6): 525â32. doi:10.1038/sj.cdd.4400519. PMID 10381646.
- Ostrerova N, Petrucelli L, Farrer M et al. (1999). "alpha-Synuclein shares physical and functional homology with 14-3-3 proteins". J. Neurosci. 19 (14): 5782â91. PMID 10407019.
- Scheid MP, Schubert KM, Duronio V (1999). "Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase". J. Biol. Chem. 274 (43): 31108â13. doi:10.1074/jbc.274.43.31108. PMID 10521512.
- Bonni A, Brunet A, West AE et al. (1999). "Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms". Science 286 (5443): 1358â62. doi:10.1126/science.286.5443.1358. PMID 10558990.
[edit] External links
- bcl-Associated Death Protein at the US National Library of Medicine Medical Subject Headings (MeSH)
|
||||||||||||||||||||||||||||||||
This page is based on a Wikipedia article. The text is available under the Creative Commons Attribution/Share-Alike License.
This tab holds the annotation information that is stored in the Pfam database. As we move to using Wikipedia as our main source of annotation, the contents of this tab will be gradually replaced by the Wikipedia tab.
Pro-apoptotic Bcl-2 protein, BAD Provide feedback
BAD is a Bcl-2 homology domain 3 (BH3)-only pro-apoptotic member of the Bcl-2 protein family that is regulated by phosphorylation in response to survival factors [1]. Binding of BAD to mitochondria is thought to be exclusively mediated by its BH3 domain. Membrane localisation of BAD mediates membrane translocation of Bcl-XL. The C-terminal part of BAD is sufficient for membrane binding. There are two segments with differing lipid-binding preferences, LBD1 and LBD2, that are responsible for this binding: (i) LBD1 located in the proximity of the BH3 domain (amino acids 122-131) and (ii) LBD2, the putative C-terminal alpha-helix-5 [2]. Phosphorylation-regulated 14-3-3 protein binding may expose the cholesterol-preferring LBD1 and bury the LBD2, thereby mediating translocation of BAD to raft-like micro-domains [3].
Literature references
-
Kelekar A, Chang BS, Harlan JE, Fesik SW, Thompson CB; , Mol Cell Biol. 1997;17:7040-7046.: Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. PUBMED:9372935 EPMC:9372935
-
She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N; , Cancer Cell. 2005;8:287-297.: The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. PUBMED:16226704 EPMC:16226704
-
Hekman M, Albert S, Galmiche A, Rennefahrt UE, Fueller J, Fischer A, Puehringer D, Wiese S, Rapp UR; , J Biol Chem. 2006;281:17321-17336.: Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding. PUBMED:16603546 EPMC:16603546
External database links
| PANDIT: | PF10514 |
| Pseudofam: | PF10514 |
| SYSTERS: | Bcl-2_BAD |
This tab holds annotation information from the InterPro database.
InterPro entry IPR018868
BAD is a Bcl-2 homology domain 3 (BH3)-only pro-apoptotic member of the Bcl-2 protein family that is regulated by phosphorylation in response to survival factors [PUBMED:9372935]. Binding of BAD to mitochondria is thought to be exclusively mediated by its BH3 domain. Membrane localisation of BAD mediates membrane translocation of Bcl-XL. The C-terminal part of BAD is sufficient for membrane binding. There are two segments with differing lipid-binding preferences, LBD1 and LBD2, that are responsible for this binding: (i) LBD1 located in the proximity of the BH3 domain (amino acids 122-131) and (ii) LBD2, the putative C-terminal alpha-helix-5 [PUBMED:16226704]. Phosphorylation-regulated 14-3-3 protein binding may expose the cholesterol-preferring LBD1 and bury the LBD2, thereby mediating translocation of BAD to raft-like micro-domains [PUBMED:16603546].
Domain organisation
Below is a listing of the unique domain organisations or architectures in which this domain is found. More...
Loading domain graphics...
Alignments
We store a range of different sequence alignments for families. As well as the seed alignment from which the family is built, we provide the full alignment, generated by searching the sequence database using the family HMM. We also generate alignments using four representative proteomes (RP) sets, the NCBI sequence database, and our metagenomics sequence database. More...
View options
We make a range of alignments for each Pfam-A family. You can see a description of each above. You can view these alignments in various ways but please note that some types of alignment are never generated while others may not be available for all families, most commonly because the alignments are too large to handle.
| Seed (4) |
Full (66) |
Representative proteomes | NCBI (48) |
Meta (0) |
||||
|---|---|---|---|---|---|---|---|---|
| RP15 (1) |
RP35 (4) |
RP55 (9) |
RP75 (24) |
|||||
| Jalview | ||||||||
| HTML | ||||||||
| PP/heatmap | 1 | |||||||
| Pfam viewer | ||||||||
1Cannot generate PP/Heatmap alignments for seeds; no PP data available
Key:
available,
not generated,
— not available.
Format an alignment
Download options
We make all of our alignments available in Stockholm format. You can download them here as raw, plain text files or as gzip-compressed files.
| Seed (4) |
Full (66) |
Representative proteomes | NCBI (48) |
Meta (0) |
||||
|---|---|---|---|---|---|---|---|---|
| RP15 (1) |
RP35 (4) |
RP55 (9) |
RP75 (24) |
|||||
| Raw Stockholm | ||||||||
| Gzipped | ||||||||
You can also download a FASTA format file containing the full-length sequences for all sequences in the full alignment.
External links
MyHits provides a collection of tools to handle multiple sequence alignments. For example, one can refine a seed alignment (sequence addition or removal, re-alignment or manual edition) and then search databases for remote homologs using HMMER3.
HMM logo
HMM logos is one way of visualising profile HMMs. Logos provide a quick overview of the properties of an HMM in a graphical form. You can see a more detailed description of HMM logos and find out how you can interpret them here. More...
Trees
This page displays the phylogenetic tree for this family's seed alignment. We use FastTree to calculate neighbour join trees with a local bootstrap based on 100 resamples (shown next to the tree nodes). FastTree calculates approximately-maximum-likelihood phylogenetic trees from our seed alignment.
Note: You can also download the data file for the tree.
Curation and family details
This section shows the detailed information about the Pfam family. You can see the definitions of many of the terms in this section in the glossary and a fuller explanation of the scoring system that we use in the scores section of the help pages.
Curation
| Seed source: | TreeFam_TF102001 |
| Previous IDs: | none |
| Type: | Family |
| Author: | Buljan M, Coggill P |
| Number in seed: | 4 |
| Number in full: | 66 |
| Average length of the domain: | 140.30 aa |
| Average identity of full alignment: | 56 % |
| Average coverage of the sequence by the domain: | 92.03 % |
HMM information
| HMM build commands: |
build method: hmmbuild -o /dev/null HMM SEED
search method: hmmsearch -Z 23193494 -E 1000 --cpu 4 HMM pfamseq
|
||||||||||||
| Model details: |
|
||||||||||||
| Model length: | 167 | ||||||||||||
| Family (HMM) version: | 4 | ||||||||||||
| Download: | download the raw HMM for this family |
Species distribution
Sunburst controls
ShowThis visualisation provides a simple graphical representation of the distribution of this family across species. You can find the original interactive tree in the adjacent tab. More...
Tree controls
HideThe tree shows the occurrence of this domain across different species. More...
Loading...
Please note: for large trees this can take some time. While the tree is loading, you can safely switch away from this tab but if you browse away from the family page entirely, the tree will not be loaded.
Structures
For those sequences which have a structure in the Protein DataBank, we use the mapping between UniProt, PDB and Pfam coordinate systems from the PDBe group, to allow us to map Pfam domains onto UniProt sequences and three-dimensional protein structures. The table below shows the structures on which the Bcl-2_BAD domain has been found. There are 2 instances of this domain found in the PDB. Note that there may be multiple copies of the domain in a single PDB structure, since many structures contain multiple copies of the same protein seqence.
Loading structure mapping...

Archea
Eukaryota
Bacteria
Other sequences
Viruses
Unclassified
Viroids
Unclassified sequence